Published in Biochemistry on April 03, 1990
Fano-resonant asymmetric metamaterials for ultrasensitive spectroscopy and identification of molecular monolayers. Nat Mater (2011) 1.72
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
Infrared assessment of bone quality: a review. Clin Orthop Relat Res (2011) 1.63
Applications of 2D IR spectroscopy to peptides, proteins, and hydrogen-bond dynamics. J Phys Chem B (2009) 1.54
Conformational transitions in model silk peptides. Biophys J (2000) 1.51
Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. Proc Natl Acad Sci U S A (1997) 1.33
Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra. Biochemistry (2011) 1.27
Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. J Pharm Sci (2009) 1.18
Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies. Biomaterials (2011) 1.18
A common beta-sheet architecture underlies in vitro and in vivo beta2-microglobulin amyloid fibrils. J Biol Chem (2008) 1.14
Precipitation of a monoclonal antibody by soluble tungsten. J Pharm Sci (2009) 1.10
Self-assembly of the ionic peptide EAK16: the effect of charge distributions on self-assembly. Biophys J (2004) 1.10
Glutamine, glutamate, and alpha-glucosylglycerate are the major osmotic solutes accumulated by Erwinia chrysanthemi strain 3937. Appl Environ Microbiol (2004) 1.09
Effect of hydration on silk film material properties. Macromol Biosci (2010) 1.09
Do parallel beta-helix proteins have a unique fourier transform infrared spectrum? Biophys J (2000) 1.05
Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations. AAPS PharmSci (2003) 1.03
Effects of sucrose on conformational equilibria and fluctuations within the native-state ensemble of proteins. Protein Sci (2003) 1.02
Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-beta aggregates. Proc Natl Acad Sci U S A (2010) 1.01
Increased aggregation propensity of IgG2 subclass over IgG1: role of conformational changes and covalent character in isolated aggregates. Protein Sci (2010) 1.00
Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydration. Biophys J (1996) 1.00
Protein thermal aggregation involves distinct regions: sequential events in the heat-induced unfolding and aggregation of hemoglobin. Biophys J (2004) 1.00
Protein structural perturbation and aggregation on homogeneous surfaces. Biophys J (2004) 0.99
Two-dimensional infrared correlation spectroscopy study of the aggregation of cytochrome c in the presence of dimyristoylphosphatidylglycerol. Biophys J (2001) 0.99
Multidimensional methods for the formulation of biopharmaceuticals and vaccines. J Pharm Sci (2011) 0.98
Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies. J Pharm Sci (2009) 0.98
Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution. Biophys J (1996) 0.96
Two-dimensional infrared correlation spectroscopy study of sequential events in the heat-induced unfolding and aggregation process of myoglobin. Biophys J (2003) 0.94
Protein conformation in amorphous solids by FTIR and by hydrogen/deuterium exchange with mass spectrometry. Biophys J (2008) 0.92
Dynamics of antifreeze glycoproteins in the presence of ice. Biophys J (2002) 0.91
The α-helix to β-sheet transition in stretched and compressed hydrated fibrin clots. Biophys J (2012) 0.90
Dissecting the mechanism of Epac activation via hydrogen-deuterium exchange FT-IR and structural modeling. Biochemistry (2006) 0.90
Flavonoids affect actin functions in cytoplasm and nucleus. Biophys J (2007) 0.90
Pressure versus temperature unfolding of ribonuclease A: an FTIR spectroscopic characterization of 10 variants at the carboxy-terminal site. Protein Sci (2001) 0.90
Detection of peptide-lipid interactions in mixed monolayers, using isotherms, atomic force microscopy, and fourier transform infrared analyses. Biophys J (2000) 0.88
Interactions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1). Clin Exp Immunol (1995) 0.88
Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: permeability and fourier transform infrared spectroscopy studies. AAPS PharmSciTech (2003) 0.87
Vibrational spectroscopic imaging for the evaluation of matrix and mineral chemistry. Curr Osteoporos Rep (2014) 0.87
Thermal aggregation and ion-induced cold-gelation of bovine serum albumin. Eur Biophys J (2009) 0.87
High-pressure refolding of bikunin: efficacy and thermodynamics. Protein Sci (2004) 0.87
Evidence for the presence of a secondary structure at the dibasic processing site of prohormone: the pro-ocytocin model. EMBO J (1992) 0.87
Analysis of conformational changes in bacteriorhodopsin upon retinal removal. Biophys J (1996) 0.86
Impact of silk biomaterial structure on proteolysis. Acta Biomater (2014) 0.86
Comparison of the solution conformation and dynamics of antifreeze glycoproteins from Antarctic fish. Biophys J (2000) 0.86
Subcellular biochemical investigation of purkinje neurons using synchrotron radiation fourier transform infrared spectroscopic imaging with a focal plane array detector. ACS Chem Neurosci (2013) 0.86
Effect of vacuum drying on protein-mannitol interactions: the physical state of mannitol and protein structure in the dried state. AAPS PharmSciTech (2004) 0.85
Role of partial protein unfolding in alcohol-induced protein aggregation. Proteins (2010) 0.85
Mechanisms of monoclonal antibody stabilization and release from silk biomaterials. Biomaterials (2013) 0.85
Secondary structure and Pd(II) coordination in S-layer proteins from Bacillus sphaericus studied by infrared and X-ray absorption spectroscopy. Biophys J (2006) 0.84
Enzyme-linked immunosorbent assay-based method to quantify the association of small molecules with aggregated amyloid peptides. Anal Chem (2012) 0.84
Fourier transform infrared analysis and bone. Osteoporos Int (2009) 0.84
Characterization of a cyclosporine solid dispersion for inhalation. AAPS J (2007) 0.82
Mechanisms of m-cresol-induced protein aggregation studied using a model protein cytochrome c. J Pharm Sci (2011) 0.82
Characteristics of the Aragonitic Layer in Adult Oyster Shells, Crassostrea gigas: Structural Study of Myostracum including the Adductor Muscle Scar. Evid Based Complement Alternat Med (2011) 0.81
Analysis of casein biopolymers adsorption to lignocellulosic biomass as a potential cellulase stabilizer. J Biomed Biotechnol (2012) 0.81
Aligned silk-based 3-D architectures for contact guidance in tissue engineering. Acta Biomater (2011) 0.81
Infrared spectroscopic discrimination between the loop and alpha-helices and determination of the loop diffusion kinetics by temperature-jump time-resolved infrared spectroscopy for cytochrome c. Biophys J (2007) 0.81
Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain. Biochemistry (2012) 0.81
Secondary structure of rhBMP-2 in a protective biopolymeric carrier material. Biomacromolecules (2012) 0.80
Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: development of a novel process for obtaining a dry, stable powder. AAPS PharmSci (2004) 0.80
Retracted Overestimated accuracy of circular dichroism in determining protein secondary structure. Eur Biophys J (2013) 0.80
Cellulose, Chitosan and Keratin Composite Materials: Facile and Recyclable Synthesis, Conformation and Properties. ACS Sustain Chem Eng (2016) 0.80
Thermal-induced dissociation and unfolding of homodimeric DsbC revealed by temperature-jump time-resolved infrared spectra. Biophys J (2009) 0.79
High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies. Protein Sci (2005) 0.79
Fourier transform infrared spectroscopic study of Ca2+ and membrane-induced secondary structural changes in bovine prothrombin and prothrombin fragment 1. Biophys J (1991) 0.79
A conserved helical capping hydrogen bond in PAS domains controls signaling kinetics in the superfamily prototype photoactive yellow protein. J Am Chem Soc (2010) 0.79
Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids. Pharm Res (2008) 0.79
Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy. Osteoporos Int (2014) 0.79
Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation. Int J Nanomedicine (2015) 0.78
A green approach to the synthesis of novel "Desert rose stone"-like nanobiocatalytic system with excellent enzyme activity and stability. Sci Rep (2014) 0.78
Heterogeneity of equilibrium molten globule state of cytochrome c induced by weak salt denaturants under physiological condition. PLoS One (2015) 0.77
UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. Eur J Pharm Biopharm (2014) 0.77
S-layer templated bioinspired synthesis of silica. Colloids Surf B Biointerfaces (2009) 0.77
EC-QCL mid-IR transmission spectroscopy for monitoring dynamic changes of protein secondary structure in aqueous solution on the example of β-aggregation in alcohol-denaturated α-chymotrypsin. Anal Bioanal Chem (2016) 0.76
Time Related Changes of Mineral and Collagen and Their Roles in Cortical Bone Mechanics of Ovariectomized Rabbits. PLoS One (2015) 0.76
Deducing conformational variability of intrinsically disordered proteins from infrared spectroscopy with Bayesian statistics. Chem Phys (2013) 0.76
Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface. Eur J Pharm Biopharm (2014) 0.76
Serish inulin and wheat biopolymers interactions in model systems as a basis for understanding the impact of inulin on bread properties: a FTIR investigation. J Food Sci Technol (2015) 0.75
Classification and identification of Rhodobryum roseum Limpr. and its adulterants based on fourier-transform infrared spectroscopy (FTIR) and chemometrics. PLoS One (2017) 0.75
Infrared metrics for fixation-free liver tumor detection. J Phys Chem B (2013) 0.75
Identification of fibrillogenic regions in human triosephosphate isomerase. PeerJ (2016) 0.75
A new criterion to evaluate water vapor interference in protein secondary structural analysis by FTIR spectroscopy. Int J Mol Sci (2014) 0.75
Computing infrared spectra of proteins using the exciton model. J Comput Chem (2016) 0.75
Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: Development of a novel process for obtaining a dry, stable powder. AAPS J (2004) 0.75
β-Aminopropionitrile-Induced Reduction in Enzymatic Crosslinking Causes In Vitro Changes in Collagen Morphology and Molecular Composition. PLoS One (2016) 0.75
Probing the catalytic allosteric mechanism of rabbit muscle pyruvate kinase by tryptophan fluorescence quenching. Eur Biophys J (2012) 0.75
Subtilase from Beauveria sp.: conformational and functional investigation of unusual stability. Eur Biophys J (2014) 0.75
Vibrational spectroscopic techniques to assess bone quality. Osteoporos Int (2017) 0.75
Infrared spectroscopic characterization of copper-polyhistidine from 1,800 to 50 cm(-1): model systems for copper coordination. J Biol Inorg Chem (2008) 0.75
Calculation of the infrared spectra of proteins. Eur Biophys J (2014) 0.75
Photoacoustic spectroscopy of aromatic amino acids in proteins. Eur Biophys J (2007) 0.75
Glycolysis inhibition for anticancer treatment. Oncogene (2006) 6.55
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry (1991) 5.53
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1998) 3.23
Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22
Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol (1995) 2.57
Porphyrin and phthalocyanine antiscrapie compounds. Science (2000) 2.54
An infrared study of CO binding to heart cytochrome c oxidase and hemoglobin A. Implications re O2 reactions. J Biol Chem (1977) 2.36
CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells. Int Endod J (2013) 2.03
Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene (2010) 1.88
Mössbauer spectroscopy of heme and hemin compounds. Proc Natl Acad Sci U S A (1965) 1.86
The diverse roles of J-proteins, the obligate Hsp70 co-chaperone. Rev Physiol Biochem Pharmacol (2006) 1.83
Gemcitabine: preclinical pharmacology and mechanisms of action. Semin Oncol (1996) 1.81
Structure of carboxymyoglobin in crystals and in solution. Proc Natl Acad Sci U S A (1979) 1.79
An infrared study of NO bonding to heme B and hemoglobin A. Evidence for inositol hexaphosphate induced cleavage of proximal histidine to iron bonds. Biochemistry (1976) 1.71
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology (2006) 1.69
Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob Control (2004) 1.64
G alpha(o) is necessary for muscarinic regulation of Ca2+ channels in mouse heart. Proc Natl Acad Sci U S A (1997) 1.48
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke (2000) 1.40
Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J (2000) 1.38
Priming of insulin granules for exocytosis by granular Cl(-) uptake and acidification. J Cell Sci (2001) 1.37
Investigations of cyanide as an infrared probe of hemeprotein ligand binding sites. J Biol Chem (1985) 1.36
Dynamic protein structures: infrared evidence for four discrete rapidly interconverting conformers at the carbon monoxide binding site of bovine heart myoglobin. Proc Natl Acad Sci U S A (1981) 1.34
Carbon monoxide bonding in hemeproteins. Ann N Y Acad Sci (1970) 1.34
The effects of alcohols on lipid bilayers: a spin label study. Biochim Biophys Acta (1972) 1.33
Preclinical characteristics of gemcitabine. Anticancer Drugs (1995) 1.31
MAP 30: a new inhibitor of HIV-1 infection and replication. FEBS Lett (1990) 1.30
Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol (2001) 1.29
Elucidation of the mode of binding of oxygen to iron in oxyhemoglobin by in frared spectroscopy. Biochem Biophys Res Commun (1973) 1.28
Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J Virol (1999) 1.28
Mechanism of autooxidation for hemoglobins and myoglobins. Promotion of superoxide production by protons and anions. J Biol Chem (1982) 1.27
Analysis of the spectra and redox properties of pure cytochromes aa3. Biophys J (1986) 1.26
Structure of hemoglobins Zürich [His E7(63)beta replaced by Arg] and Sydney [Val E11(67)beta replaced by Ala] and role of the distal residues in ligand binding. Proc Natl Acad Sci U S A (1978) 1.25
Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J Hepatol (2001) 1.24
Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1998) 1.23
A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol (2006) 1.23
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest. Mol Pharmacol (2001) 1.22
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway. Cell Death Differ (2013) 1.22
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism. Leukemia (2008) 1.21
Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. Blood (1997) 1.20
Destabilizing effects of replacing a surface lysine of cytochrome c with aromatic amino acids: implications for the denatured state. Biochemistry (1993) 1.20
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia (2004) 1.20
Evolutionary characterization of recent human H3N2 influenza A isolates from Japan and China: novel changes in the receptor binding domain. Arch Virol (1996) 1.19
Infrared methods for study of hemoglobin reactions and structures. Methods Enzymol (1994) 1.18
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells. Leukemia (2005) 1.18
Identification of an N-terminal amino acid of the CLC-3 chloride channel critical in phosphorylation-dependent activation of a CaMKII-activated chloride current. J Physiol (2004) 1.17
Divergent functional properties of the ribosome-associated molecular chaperone Ssb compared with other Hsp70s. Mol Biol Cell (2001) 1.17
Dynamic protein structures. Effects of pH on conformer stabilities at the ligand-binding site of bovine heart myoglobin carbonyl. J Biol Chem (1982) 1.15
An infrared study of bound carbon monoxide in the human red blood cell, isolated hemoglobin, and heme carbonyls. Biochemistry (1968) 1.15
Texas Tobacco Prevention Pilot Initiative: processes and effects. Health Educ Res (2004) 1.14
S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine. Cancer Res (2001) 1.13
Heme A of cytochrome c oxicase. Structure and properties: comparisons with hemes B, C, and S and derivatives. J Biol Chem (1975) 1.12
Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase. Immunity (2000) 1.10
Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. Cancer Res (2001) 1.09
TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells. Proc Natl Acad Sci U S A (1991) 1.09
Infrared spectra of carbonyl hemoglobins: characterization of dynamic heme pocket conformers. Biochemistry (1990) 1.07
Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol (2000) 1.06
Cloning and characterization of a cDNA encoding beta-amyrin synthase involved in glycyrrhizin and soyasaponin biosyntheses in licorice. Biol Pharm Bull (2001) 1.06
Mechanism for the autoxidation of hemoglobin by phenols, nitrite and "oxidant" drugs. Peroxide formation by one electron donation to bound dioxygen. Biochem Biophys Res Commun (1975) 1.06
Bovine heart cytochrome c oxidase preparations contain high affinity binding sites for magnesium as well as for zinc, copper, and heme iron. Biochem Biophys Res Commun (1985) 1.05
Distinct long-term neurocognitive outcomes after equipotent sevoflurane or isoflurane anaesthesia in immature rats. Br J Anaesth (2013) 1.04
Proton magnetic resonance studies of porphyrin iron (3) cyanides. Proc Natl Acad Sci U S A (1969) 1.04
Infrared evidence of cyanide binding to iron and copper sites in bovine heart cytochrome c oxidase. Implications regarding oxygen reduction. J Biol Chem (1990) 1.03
Mossbauer spectroscopic evidence for low-spin iron in dehydrated metmyoglobin. Biochemistry (1966) 1.03
Oxygen infrared spectra of oxyhemoglobins and oxymyoglobins. Evidence of two major liganded O2 structures. Biochemistry (1987) 1.03
Anti-HIV plant proteins catalyze topological changes of DNA into inactive forms. Biofactors (1992) 1.02
Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds? Acc Chem Res (2006) 1.02
Salicylhydroxamic acid inhibits myeloperoxidase activity. J Biol Chem (1991) 1.02
Effects of overall oxidation state on infrared spectra of heme a3 cyanide in bovine heart cytochrome c oxidase. Evidence of novel mechanistic roles for CuB. J Biol Chem (1995) 1.02
Oxygenation of carbon monoxide by bovine heart cytochrome c oxidase. Biochemistry (1986) 1.01
Redox-dependent changes in beta-extended chain and turn structures of cytochrome c in water solution determined by second derivative amide I infrared spectra. Biochemistry (1992) 1.01
Magnetic and spectroscopic probes for FeOFe linkages in hemin systems. Bioinorg Chem (1975) 1.01
A new class of anti-HIV agents: GAP31, DAPs 30 and 32. FEBS Lett (1991) 1.01
Substituted deuteroporphyrins. I. Reactions at the periphery of the porphyrin ring. J Org Chem (1966) 1.01
Substituted deuteroporphyrins. 3. Iron (II) derivatives. Reactions with oxygen and preparations from chloro- and methoxohemins. Biochemistry (1968) 1.00
Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopy. Proc Natl Acad Sci U S A (1989) 1.00
Heart cytochrome c oxidase. An infrared study of effects of oxidation state on carbon monoxide binding. J Biol Chem (1982) 1.00
Insulin-receptor and apolipoprotein genes contribute to development of NIDDM in Chinese Americans. Diabetes (1989) 1.00
The site and mechanism of dioxygen reduction in bovine heart cytochrome c oxidase. J Biol Chem (1988) 0.99
Metabolism and action of fludarabine phosphate. Semin Oncol (1990) 0.99
Reduced expression of the μ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G. Neuroscience (2012) 0.98
Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J Neurosci (1999) 0.98
Cytochrome c oxidase catalysis of the reduction of nitric oxide to nitrous oxide. Biochem Biophys Res Commun (1995) 0.97
Infrared spectroscopy of ligands, gases, and other groups in aqueous solutions and tissue. Methods Enzymol (1978) 0.96
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies. Semin Oncol (1993) 0.96
Zinc is a constituent of bovine heart cytochrome c oxidase preparations. Biochem Biophys Res Commun (1984) 0.95
Evidence from infrared and 13C NMR spectra for discrete rapidly interconverting conformers at the carbon monoxide binding sites of hemoglobins A and Zurich. J Biol Chem (1981) 0.95
The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors. Biochemistry (2000) 0.95
Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy. J Refract Surg (2001) 0.95
Reactions of oxygen with hemoglobin, cytochrome c oxidase and other hemeproteins. Ann N Y Acad Sci (1975) 0.95
Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation. Mol Pharmacol (2001) 0.95
Surface analyses of micro-arc oxidized and hydrothermally treated titanium and effect on osteoblast behavior. J Biomed Mater Res A (2004) 0.94
Carbon-13 Fourier transform nuclear magnetic resonance study of some porphyrins. Evidence for a preferred delocalization pathway. J Am Chem Soc (1972) 0.94
Predictors of tobacco sales to minors. Prev Med (1997) 0.94
Properties of hemoglobin A and hemoglobin Zurich (beta63 histidine replaced by arginine): quantitative evaluation of functional abnormalities in hemoglobins. Biochem Biophys Res Commun (1976) 0.94
Metabolism of dihalomethanes to carbon monoxide. I. In vivo studies. Drug Metab Dispos (1974) 0.94
Effects of calcium, magnesium, and phosphorylcholine on secondary structures of human C-reactive protein and serum amyloid P component observed by infrared spectroscopy. J Biol Chem (1994) 0.93
Mössbauer studies of bonding in iron porphyrin-ligand systems. J Chem Phys (1969) 0.92
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C. Leukemia (2006) 0.92
Quantitative infrared spectroscopy of CO complexes of cytochrome c oxidase, hemoglobin and myoglobin: evidence for one CO per heme. Biochem Biophys Res Commun (1975) 0.91